Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNo significant changes detected; the study details, enrollment, locations, and primary/secondary outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check26 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Schizophrenia; overall page content in the genetics/health topic area is reduced.SummaryDifference0.2%

- Check33 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check41 days agoChange DetectedPage version updated to v3.1.0 with a new MedlinePlus Genetics topic on Schizophrenia; previous version v3.0.2 removed.SummaryDifference0.3%

- Check48 days agoChange Detected- Removed a MedlinePlus Genetics topic on schizophrenia, narrowing the page's coverage of that condition.SummaryDifference0.2%

- Check55 days agoChange DetectedUpdated the page to revision v3.0.2 and removed the 'Back to Top' link; no substantive content changes were detected.SummaryDifference0.2%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.